AzTrials
AzTrials

Tinnitus, SubjectiveEEG-RCTNCT04449237

Mechanism Research of Tinnitus Based on Electroencephalogram and Acoustic Therapy Intervention

A study testing music therapy in people with Tinnitus, Subjective, run by Eye & ENT Hospital of Fudan University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This project aims to systematically and deeply study the central mechanism of tinnitus using electroencephalogram, and further study the treatment mechanism of tinnitus in combination with sound treatment strategies, so as to provide a research basis for clinical treatment of tinnitus. Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Tinnitus, Subjective
What is being tested?
music therapy
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
100 participants
Where
No sites listed yet
Study dates
1 Jul 2020to 30 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 18-30 years old, male or female;
  • PTA (0.5,1,2kHz) ≤25dB HL;
  • Tinnitus is a major problem faced by patients (except healthy volunteers);
  • tinnitus course > for 3 months;
  • Healthy, no history of other ear diseases, no history of hearing impairment;
  • There are no other medical, psychological or social problems that need urgent treatment, and no other problems that interfere with tinnitus-related treatment;
  • Voluntary tinnitus treatment, and have enough time to cooperate with treatment.

Who cannot join

  • Pulsatile tinnitus;
  • Acute tinnitus;
  • Tinnitus is associated with severe hearing loss;
  • Tinnitus accompanied by vertigo;
  • Tinnitus accompanied by headache;
  • Tinnitus is accompanied by somatic symptoms, such as neck pain and temporomandibular joint disorder;
  • Post-traumatic tinnitus;
  • Tinnitus is associated with serious psychiatric complications;

About this study

Official title: The Mechanism Research of Tinnitus Based on Electroencephalogram and Acoustic Therapy Intervention

This project aims to systematically and deeply study the central mechanism of tinnitus using electroencephalogram, and further study the treatment mechanism of tinnitus in combination with sound treatment strategies, so as to provide a research basis for clinical treatment of tinnitus.

Read the detailed description

Tinnitus is one of the most common auditory disturbances in human. The treatment of tinnitus is always not effective, and the standardized treatment of tinnitus has been lacking. With the development of neuroimaging, neuroelectrophysiology and animal models of tinnitus, the central mechanism of tinnitus has been gradually revealed. The possible mechanisms of tinnitus are the increase of spontaneous discharge rate and synchronization of auditory central neurons caused by hearing deprivation, the change of brain topological structure, the reorganization of auditory cortex, and the disorder of limbic system and auditory central regulation of tinnitus patients. EEG, as an important means to study the cerebral cortex, has become an important technical support for the research on the central mechanism of tinnitus. Changes in activity in auditory brain areas associated with tinnitus have been observed using EEG/ERPs, and non-auditory brain areas such as the limbic system and frontal cortices have also been associated with tinnitus mechanisms. This project aims to systematically and deeply study the central mechanism of tinnitus using electroencephalogram, and further study the treatment mechanism of tinnitus in combination with sound treatment strategies, so as to provide a research basis for clinical treatment of tinnitus.

Being tested
music therapy
Medical subject headings
Tinnitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • music therapyOther

    music therapy: therapeutic sound according to the frequency and loudness of each patient's tinnitus sound, so as to reduce the tinnitus sound.

Study groups in NCT04449237
Study groupRoleWhat they receive
volunteerOther40 volunteer will not accept any treatment
Receives: Other: music therapy
patients with unmodified music groupPlacebo comparator40 participants in this group will listen to music without any modification
Receives: Other: music therapy
patients with modified tinnitus relieving musicExperimental40 participants in this group will listen to the music modified according to the matched dominant tinnitus pitch
Receives: Other: music therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. electroencephalogram evaluation

    latency

    Measured: From date of randomization, assessed every 3 month, up to 24 month

  2. electroencephalogram evaluation

    peak

    Measured: From date of randomization, assessed every 3 month, up to 24 month

  3. electroencephalogram evaluation

    amplitude

    Measured: From date of randomization, assessed every 3 month, up to 24 month

  4. the loudness of tinnitus

    estimated by auditory facility, recorded by unit of dB

    Measured: From date of randomization, assessed every 3 month, up to 24 month

  5. the frequency of tinnitus

    estimated by auditory facility, recorded by unit of Hz

    Measured: From date of randomization, assessed every 3 month, up to 24 month

  6. minimum masking level

    the minimum volume to masking tinnitus, recorded by unit of dB

    Measured: From date of randomization, assessed every 3 month, up to 24 month

  7. Tinnitus Handicapped Inventory

    Tinnitus disability is divided into four levels, the first level:

    0-16 points, no disability; Level 2:18-36, slightly disabled; Level 3:38-56, moderate disability; Level 4:58-100, severe disability.

    Measured: From date of randomization, assessed every 3 month, up to 24 month

  8. Hospital Anxiety and Distress Scale

    0-7 are asymptomatic; 8 -10 respectively belong to suspicious existence; 11 -21 must exist.

    Measured: From date of randomization, assessed every 3 month, up to 24 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2020
  2. Study start1 Jul 2020 (estimated)
  3. Primary completion30 Jun 2022 (estimated)
  4. Study completion30 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04449237
Sponsor's protocol ID
sunshan
Acronym
EEG-RCT
Status last verified
Jul 2020
First submitted
16 Jun 2020
Last updated
7 Jul 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing music therapy in people with Tinnitus, Subjective, run by Eye & ENT Hospital of Fudan University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

electroencephalogram evaluation (time frame: From date of randomization, assessed every 3 month, up to 24 month). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in